Among 41 nodules (57.8%) identified with neither RAS, BRAF V600E, nor TERT promoter variants, 17 were benign tumors, 1 was NIFTP, 14 were CPTCs, and 9 were IEFVPTCs. Here, BRAF is linked to benign neoplasm.